v3.26.1
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity

A summary of iMDx’s 2010 Plan and 2018 Incentive Plan activity and related information follows:

 

 

Options

 

 

Nonvested RSUs

 

 

Number
Outstanding

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Life

 

Aggregate
Intrinsic
Value

 

 

Number
Outstanding

 

 

Weighted
Average
Grant
Date Fair
Value

 

 

(In thousands, except weighted average amounts)

 

Balance at December 31, 2024

 

 

1,091

 

 

$

12.42

 

 

8.56 years

 

$

—

 

 

 

100

 

 

$

1.73

 

Awards granted

 

 

1,308

 

 

$

3.38

 

 

 

 

 

 

 

 

838

 

 

$

3.14

 

Options exercised

 

 

—

 

 

$

—

 

 

 

 

$

—

 

 

n/a

 

 

n/a

 

RSUs vested

 

n/a

 

 

n/a

 

 

 

 

 

 

 

 

(86

)

 

$

2.55

 

Options forfeited/expired

 

 

(148

)

 

$

13.28

 

 

 

 

 

 

 

n/a

 

 

n/a

 

RSUs forfeited

 

n/a

 

 

n/a

 

 

 

 

 

 

 

 

—

 

 

$

—

 

Balance at December 31, 2025

 

 

2,251

 

 

$

7.11

 

 

8.92 years

 

$

8,537

 

 

 

852

 

 

$

3.03

 

Options vested and expected to vest at December 31, 2025

 

 

2,251

 

 

$

7.11

 

 

8.92 years

 

$

8,537

 

 

 

 

 

 

 

Options exercisable at December 31, 2025

 

 

566

 

 

$

18.21

 

 

7.38 years

 

$

1,523

 

 

 

 

 

 

 

Stock-based compensation expense for the period

 

$

1,423

 

 

 

 

 

 

 

 

 

 

$

796

 

 

 

 

Unrecognized stock-based compensation expense

 

$

3,857

 

 

 

 

 

 

 

 

 

 

$

1,923

 

 

 

 

Weighted average remaining recognition period

 

2.58 years

 

 

 

 

 

 

 

 

 

 

2.55 years

 

 

 

 
Schedule of Assumptions Used to Calculate Fair Value of Stock Options The assumptions used to calculate the Black-Scholes grant date fair value for such time-based awards were as follows:

 

 

Years Ended
December 31,

 

 

2025

 

 

2024

 

Expected life

 

6.19 years

 

 

7.37 years

 

Risk-free interest rates

 

 

3.83

%

 

 

4.31

%

Volatility

 

 

89.98

%

 

 

106.32

%

Dividend yield

 

 

0

%

 

 

0

%
Summary of Stock-based Compensation Expense

iMDx recorded stock-based compensation expense in the following categories on the accompanying consolidated statements of operations:

 

 

Years Ended
December 31,

 

 

2025

 

 

2024

 

 

(In thousands)

 

Cost of revenues

 

$

—

 

 

$

—

 

Research and development

 

 

721

 

 

 

810

 

Sales and marketing

 

 

181

 

 

 

174

 

General and administrative

 

 

1,317

 

 

 

769

 

Total

 

$

2,219

 

 

$

1,753